HONG KONG, April 7, 2022 /PRNewswire/ — SIMCERE PHARMA (HK.2096), an innovation and R&D-driven pharmaceutical company with a mission of “providing today’s patients with medicines of the future”, will host a virtual R&D Day, on Friday, 15 April, 2022, at 21:00-23:00 (HKT) / 9:00-11:00 (EST) / 13:00-15:00 (GMT).
The R&D Day will feature presentations from Mr. Ren Jinsheng(Chairman of the Board & CEO), Mr. Zhou Gaobo(CIO), Dr. Tang Renhong(EVP), Dr. Bijoyesh Mookerjee(CMO), Dr. Danny Chen(SVP) and Dr. Kevin Oliver(SVP).
A live question and answer session will follow. To register for the event, please click here (https://www.simcere.com/xs2022/).
For further information, please contact:
Jason Bao, The Secretary of the Board
E-mail: ir@simcere.com
About Simcere
Simcere Pharmaceutical Group is an innovation and R&D-driven pharmaceutical company. It has established a National Key Laboratory of Translational Medicine and Innovative Drug Development. The company focuses on three therapeutic areas, oncology, central nervous system, and autoimmune diseases, with forward-looking layout of disease areas that may have significant clinical needs in the future, aiming to achieve the mission of “providing today’s patients with medicines of the future.” Bases on its R&D and commercialization excellence, Simcere is in a leading position for its main products in the Chinese market. Its vigorous in-house R&D efforts and extensive R&D collaborations have made it a strategic cooperation partner with world leading innovative companies and research institutes.
Donate To The Indian Sun
Dear Reader,The Indian Sun is an independent organisation committed to community journalism. We have, through the years, been able to reach a wide audience especially with the growth of social media, where we also have a strong presence. With platforms such as YouTube videos, we have been able to engage in different forms of storytelling. However, the past few years, like many media organisations around the world, it has not been an easy path. We have a greater challenge. We believe community journalism is very important for a multicultural country like Australia. We’re not able to do everything, but we aim for some of the most interesting stories and journalism of quality. We call upon readers like you to support us and make any contribution. Do make a DONATION NOW so we can continue with the volume and quality journalism that we are able to practice.
Thank you for your support.
Best wishes,
Team The Indian Sun
